Translate AMICOR contents if you like

Monday, August 08, 2016

Lipid-lowering Therapies


Title:

LIPID-LOWERING THERAPY FOR ASCVD: GUIDELINES AND AGENTS

Topic:Cardiology
Relevant Terms:Lipid management; cardiovascular disease; athersclerosis; familial hypercholesterolemia; dyslipidemia
Primary Audience:Primary Care Physicians; Nurse Practitioners; Physician Assistants
Launch Date:04-Aug-16
Credits:0.75 AMA PRA Category 1 Credit
Expiration Date:04-Aug-17
Curriculum Name:Achieving LDL Goals in Patients with Hypercholesterolemia

LEARNING OBJECTIVES

After completing this activity, the participant will demonstrate the ability to:
  1. Discuss the limitations of currently available lipid-lowering agents and the need for novel treatment options
  2. Describe the mechanism of action, efficacy and safety of PCSK9 inhibitors and what differentiates them from other forms of lipid-lowering therapy
  3. Review the clinical trial data supporting the use of PCSK9 inhibitors to lower LDL cholesterol and ongoing outcomes trials in at-risk patients with hypercholesterolemia
  4. Apply current evidence-based therapies to optimize control of LDL-C in patients with hypercholesterolemia
+++++++++++++++++++++++++++++++++++++++++++++++++++++++
the CMECompanion will alert you when new activities become available that are relevant to your specialty. Please take a moment to review the activity list below. We hope you find it to be valuable to your CME work.

No comments: